Store-Operated Ca2+ Entry in Fibrosis and Tissue Remodeling
- PMID: 39659877
- PMCID: PMC11629433
- DOI: 10.1177/25152564241291374
Store-Operated Ca2+ Entry in Fibrosis and Tissue Remodeling
Abstract
Fibrosis is a pathological condition characterized by excessive tissue deposition of extracellular matrix (ECM) components, leading to scarring and impaired function across multiple organ systems. This complex process is mediated by a dynamic interplay between cell types, including myofibroblasts, fibroblasts, immune cells, epithelial cells, and endothelial cells, each contributing distinctively through various signaling pathways. Critical to the regulatory mechanisms involved in fibrosis is store-operated calcium entry (SOCE), a calcium entry pathway into the cytosol active at the endoplasmic reticulum-plasma membrane contact sites and common to all cells. This review addresses the multifactorial nature of fibrosis with a focus on the pivotal roles of different cell types. We highlight the essential functions of myofibroblasts in ECM production, the transformation of fibroblasts, and the participation of immune cells in modulating the fibrotic landscape. We emphasize the contributions of SOCE in these different cell types to fibrosis, by exploring the involvement of SOCE in cellular functions such as proliferation, migration, secretion, and inflammatory responses. The examination of the cellular and molecular mechanisms of fibrosis and the role of SOCE in these mechanisms offers the potential of targeting SOCE as a therapeutic strategy for mitigating or reversing fibrosis.
Keywords: Orai1; calcium release activated channel (CRAC) (ICRAC); calcium signaling; fibrosis; stromal-interaction molecule (STIM); tissue remodeling.
© The Author(s) 2024.
Conflict of interest statement
MT is a scientific advisor for companies pursuing SOCE as targets for human disease. These are Seeker Biologics (Cambridge, MA), Eldec Pharmaceuticals (Durham, NC) and Vivreon Biosciences (San Diego, CA).
Figures
Similar articles
-
Physiological functions of calcium signaling via Orai1 in cancer.J Physiol Sci. 2023 Sep 27;73(1):21. doi: 10.1186/s12576-023-00878-0. J Physiol Sci. 2023. PMID: 37759164 Free PMC article. Review.
-
STIM-TRP Pathways and Microdomain Organization: Contribution of TRPC1 in Store-Operated Ca2+ Entry: Impact on Ca2+ Signaling and Cell Function.Adv Exp Med Biol. 2017;993:159-188. doi: 10.1007/978-3-319-57732-6_9. Adv Exp Med Biol. 2017. PMID: 28900914 Review.
-
The Molecular Heterogeneity of Store-Operated Ca2+ Entry in Vascular Endothelial Cells: The Different roles of Orai1 and TRPC1/TRPC4 Channels in the Transition from Ca2+-Selective to Non-Selective Cation Currents.Int J Mol Sci. 2023 Feb 7;24(4):3259. doi: 10.3390/ijms24043259. Int J Mol Sci. 2023. PMID: 36834672 Free PMC article. Review.
-
STIM and calcium channel complexes in cancer.Biochim Biophys Acta. 2016 Jun;1863(6 Pt B):1418-26. doi: 10.1016/j.bbamcr.2015.10.003. Epub 2015 Oct 9. Biochim Biophys Acta. 2016. PMID: 26455959 Review.
-
Regulation of Store-Operated Ca2+ Entry by SARAF.Cells. 2021 Jul 26;10(8):1887. doi: 10.3390/cells10081887. Cells. 2021. PMID: 34440656 Free PMC article. Review.
Cited by
-
Fighting Bleb Fibrosis After Glaucoma Surgery: Updated Focus on Key Players and Novel Targets for Therapy.Int J Mol Sci. 2025 Mar 5;26(5):2327. doi: 10.3390/ijms26052327. Int J Mol Sci. 2025. PMID: 40076946 Free PMC article.
-
Ca2+ Signaling in Cardiac Fibroblasts: An Emerging Signaling Pathway Driving Fibrotic Remodeling in Cardiac Disorders.Biomedicines. 2025 Mar 17;13(3):734. doi: 10.3390/biomedicines13030734. Biomedicines. 2025. PMID: 40149710 Free PMC article. Review.
References
-
- Ackermann M, Stark H, Neubert L, Schubert S, Borchert P, Linz F, Wagner WL, Stiller W, Wielputz M, Hoefer A, et al. (2020). Morphomolecular motifs of pulmonary neoangiogenesis in interstitial lung diseases. Eur Respir J 55. - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous